enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
0.9135
+0.0200 (2.24%)
Aug 27, 2025, 4:00 PM - Market closed
enVVeno Medical Market Cap
enVVeno Medical has a market cap or net worth of $17.58 million as of August 27, 2025. Its market cap has decreased by -73.65% in one year.
Market Cap
17.58M
Enterprise Value
-17.06M
1-Year Change
-73.65%
Ranking
Category
Stock Price
$0.91
Market Cap Chart
Since May 31, 2018, enVVeno Medical's market cap has decreased from $40.00M to $17.58M, a decrease of -56.04%. That is a compound annual growth rate of -10.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2025 | 17.20M | -67.53% |
| Dec 31, 2024 | 52.96M | -22.63% |
| Dec 29, 2023 | 68.45M | 41.69% |
| Dec 30, 2022 | 48.31M | -22.58% |
| Dec 31, 2021 | 62.40M | 222.87% |
| Dec 31, 2020 | 19.33M | 96.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 635.15B |
| Johnson & Johnson | 430.35B |
| AbbVie | 369.09B |
| UnitedHealth Group | 277.63B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 229.39B |